UK-68,798 is a novel, potent and selective class III antiarrhythmic drug M. Gwilt, H.W. Dalrymple, R.A. Burges, K.J. Blackburn, J.E. Arrowsmith, P.E. Cross, A.J. Higgins. Pfizer Central Research, Sandwich, Kent, U.K.
- 1 April 1989
- journal article
- Published by Elsevier in Journal of Molecular and Cellular Cardiology
- Vol. 21, S11
- https://doi.org/10.1016/0022-2828(89)91533-2